Back to Search Start Over

A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising

Authors :
Paul Burton, MD, PhD, FACC
W. Frank Peacock, MD, FACEP
Source :
HeartRhythm Case Reports, Vol 2, Iss 3, Pp 248-249 (2016)
Publication Year :
2016
Publisher :
Elsevier, 2016.

Details

Language :
English
ISSN :
22140271
Volume :
2
Issue :
3
Database :
Directory of Open Access Journals
Journal :
HeartRhythm Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.42127a0b70534e409628dd5099356cf8
Document Type :
article
Full Text :
https://doi.org/10.1016/j.hrcr.2016.02.001